Page 17 - Fady Boctor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Petros Pharmaceuticals, Inc Through Exclusive Marketing Agreement with Hims & Hers Health, Inc Generates 476% Year-Over-Year Growth of STENDRA Tablet Sales

/PRNewswire/ Petros Pharmaceuticals, Inc. (Petros, Nasdaq: PTPI), a leading provider of therapeutics for men s health, today announces a 476% growth.

Patrick carrollEndo pharmaceuticalsPetros pharmaceuticalsExchange commissionPetros pharmaceuticals incSecurities exchangeAuxilium pharmaceuticalsPrnewswire petros pharmaceuticals incHims hers health incHers healthFady boctorPetros pharmaceutical presidentChief commercialChief medical officerRisk informationSecurities act

Petros Pharmaceuticals Announces Closing of $5 7 Million Registered Direct Offering

/PRNewswire/ Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men s health, today announced the closing of its previously.

Exchange commissionKatalyst securitiesPetros pharmaceuticalsPetros pharmaceuticals incFady boctorPetros pharmaceutical presidentChief commercialPetros pharmaceuticalSarbanes oxley actPetros pharmaceuticalsAnnual reportQuarterly reportsCurrent reports

Petros Pharmaceuticals Announces Second Quarter Financial Results and Provides Corporate Update; Reports a 123% Increase in Year Over Year Quarterly STENDRA® (avanafil) Net Sales

/PRNewswire/ Petros Pharmaceuticals, Inc. ("Petros" or "the Company") (Nasdaq: PTPI), a leading provider of therapeutics for men s health, today announced.

Endo pharmaceuticalsCompany nasdaqCompany board of directorsPetros pharmaceuticalsDrug administrationExchange commissionAuxilium pharmaceuticalsPetros pharmaceuticals incSecurities exchangeQuarter highlightsFady boctorPetros pharmaceutical presidentChief commercialPrescription medicinesMedical devicesMedical device

The Investor Summit: Petros Pharmaceuticals: Invitation to the Q3 Virtual Investor Summit

New Jersey and Pennsylvania (Newsfile Corp. - August 11, 2021) - Petros Pharmaceuticals (NASDAQ: PTPI) today announced that Fady Boctor, President, Chief Commercial Officer will be attending the Q3 Virtual

New jerseyUnited statesSasha murrayPennsylvania newsfile corpPetros pharmaceuticalsFady boctorChief commercial officerInvestor summitComplimentary investorபுதியது ஜெர்சிஒன்றுபட்டது மாநிலங்களில்சாஷா முர்ரேதலைமை வணிகரீதியானது அதிகாரிமுதலீட்டாளர் உச்சிமாநாடு

FDA Grants Meeting to Petros Pharmaceuticals to Discuss Label Expansion of Erectile Dysfunction Drug STENDRA®

FDA Grants Meeting to Petros Pharmaceuticals to Discuss Label Expansion of Erectile Dysfunction Drug STENDRA®
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesEndo pharmaceuticalsPetros pharmaceuticalsDrug administrationExchange commissionPetros pharmaceuticals incSecurities exchangeAuxilium pharmaceuticalsPrnewswire petros pharmaceuticals incUnited states foodFady boctorPetro presidentChief commercialDaily dosingRisk informationPrescribing information